Regular Article
PET- and MRI-Based Assessment of Glucose Utilization, Dopamine Receptor Binding, and Hemodynamic Changes after Lesions to the Caudate-Putamen in Primates

https://doi.org/10.1006/exnr.1994.1004Get rights and content

Abstract

In vivo physiological changes associated with striatal pathology were determined by measurement of glucose utilization, binding to D1 receptors and dopamine reuptake sites, regional blood flow, and behavior before and after unilateral quinolinate infusions into caudate-putamen in three nonhuman primates (Macaca fascicularis and Macaca mulata). Following the quinolinate lesion, symptoms similar to those of Huntington's disease could be induced by dopamine agonist treatment. In addition, all animals showed a long-term decrease in glucose utilization in the caudate by [18F]fluoro-2-deoxy-d-glucose positron emission tomography (PET). At 4-6 weeks following the lesion the average decrease in glucose utilization in the caudate-putamen was between 40 and 50% of the prelesion values in primates with large lesions. Corresponding caudate-putamen regional blood volume in these animals showed a 61 and 74% decrease as studied by magnetic resonance imaging with somewhat smaller changes observed in an index of cerebral blood flow. The caudate-putamen uptake rate constants for D1 receptors reflected neuronal loss and decreased by an average 40 and 48%, as determined by 11C-labeled Schering compound (SCH 39 166) and PET. Dopamine reuptake sites and fibers assessed by the 11 C-labeled cocaine analog, WIN 35 428 compound, and PET showed a temporary decrease in areas with mild neuronal loss and a long-term decrease in striatal regions with severe destruction. These results, which were consistent with behavioral changes and neuropathology seen at postmortem examination, can be related to in vivo physiological studies of Huntington's disease patients.

References (0)

Cited by (33)

  • Longitudinal characterization of cognitive and motor deficits in an excitotoxic lesion model of striatal dysfunction in non-human primates

    2019, Neurobiology of Disease
    Citation Excerpt :

    Such studies have mostly used immunohistochemistry to document changes in neurons and interneurons, by looking at the reduction in markers like DARPP-32, Calbindin, substance P, and TH, and the sparing of other cell types like ChAT and NADPH positive cells (Brownell et al., 1994; Emerich et al., 1997; Emerich et al., 2006; Ferrante et al., 1993; Roitberg et al., 2002; Schumacher et al., 1992). Only a few studies have also combined the post-mortem assessment with an in vivo characterization of the motor impairment (Brownell et al., 1994; Burns et al., 1995; Roitberg et al., 2002; Schumacher et al., 1992), and brain imaging (Hantraye et al., 1992a,b; Lavisse et al., 2015). The severity of the bilateral lesions in the striatum has been documented in rodents (Nash et al., 1991; Pettibone et al., 1978; Tulipan et al., 1986) as leading to a lethal phenotype.

  • In vivo imaging of integration and function of striatal grafts in rodent and nonhuman primate animal models

    2012, Progress in Brain Research
    Citation Excerpt :

    This indicates that a continuous decline of nigral dopamine cell function occurs following destruction of their intrinsic striatal target neurons. Other pathways were explored using the general marker of cell metabolism 18F-fluorodeoxyglucose (FDG) which also displays a severe decrease in striatal uptake following excitotoxic lesion (Brownell et al., 1994). Despite the lack of an exact understanding of the cell death mechanisms occurring in HD, major efforts are currently undertaken to find a cure.

View all citing articles on Scopus
View full text